Dr. Kai Rogers received the Best Abstract Award from the American Society for Apheresis (ASFA) for his abstract titled "A Murine Model of Extracorporeal Photopheresis as a Targeted Immunotherapy for Multiple Sclerosis," co-authored with Drs. Kathryn Eschbacher, Alexander Boyden, and Nitin Karandikar.

The announcement and presentation of the award, accompanied by a monetary prize of $500, will be a highlight of the ASFA 2024 Annual Meeting, scheduled to convene at Resorts World Las Vegas, NV.

The research investigated the potential of extracorporeal photopheresis (ECP), a known immunomodulatory procedure, within the context of a murine model of multiple sclerosis, specifically experimental autoimmune encephalomyelitis (EAE). The findings illuminate ECP's ability to alleviate EAE severity, whether administered during disease induction or post-onset, and its targeted efficacy. This study lays a solid foundation for further exploration into the mechanisms underlying ECP's protective effects and reinforces its viability as a therapeutic avenue for autoimmune disorders.

Physicians, scientists, and allied health professionals were encouraged to submit abstracts encompassing a wide spectrum of apheresis medicine, spanning research, clinical applications, education, and administrative endeavors. All accepted abstracts are slated for publication in the Journal of Clinical Apheresis.